Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Debt to Equity (2022 - 2026)

HeartSciences filings provide 4 years of Debt to Equity readings, the most recent being $0.16 for Q1 2026.

  • On a quarterly basis, Debt to Equity changed N/A to $0.16 in Q1 2026 year-over-year; TTM through Jan 2026 was $0.16, a N/A change, with the full-year FY2023 number at $2.17, up 395.67% from a year prior.
  • Debt to Equity hit $0.16 in Q1 2026 for HeartSciences, up from $0.01 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $2.17 in Q2 2023 to a low of -$3.88 in Q1 2023.
  • Median Debt to Equity over the past 4 years was $0.05 (2024), compared with a mean of -$0.35.
  • The widest YoY moves for Debt to Equity: up 395.67% in 2023, down 377.78% in 2023.
  • HeartSciences' Debt to Equity stood at $0.35 in 2022, then tumbled by 377.78% to -$0.96 in 2023, then skyrocketed by 101.28% to $0.01 in 2024, then surged by 1190.62% to $0.16 in 2026.
  • The last three reported values for Debt to Equity were $0.16 (Q1 2026), $0.01 (Q4 2024), and $0.08 (Q3 2024) per Business Quant data.